<div class="container">

<table style="width: 100%;"><tr>
<td>dat.ck</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Example data set: Comparing creatine kinase levels between COVID-19 survivors and nonsurvivors (cleaned version)</h2>

<h3>Description</h3>

<p>A data set from the meta-analysis of Katzenschlager et al. (2021). Specifically, this data set corresponds to the meta-analysis comparing creatine kinase (CK) levels of COVID-19 infected patients who died and those who survived. The unit of measurement for the CK levels is U/L. The rows in the data set correspond to the primary studies. Compared to the "raw" version (i.e., <code>dat.asat_raw</code>), this data set excludes the primary study of Qi et al. (2021) due to its small sample size in the nonsurvivor group.
</p>


<h3>Usage</h3>

<pre><code class="language-R">dat.ck
</code></pre>


<h3>Format</h3>

<p>A data frame with 17 rows and 13 columns:
</p>

<table>
<tr>
<td style="text-align: left;">
  <code>author</code> </td>
<td style="text-align: left;"> first author of the primary study and the journal name. </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>n.g1</code> </td>
<td style="text-align: left;"> number of subjects (nonsurvivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>q1.g1</code> </td>
<td style="text-align: left;"> first quartile of the CK levels (nonsurvivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>med.g1</code> </td>
<td style="text-align: left;"> median CK level (nonsurvivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>q3.g1</code> </td>
<td style="text-align: left;"> third quartile of the CK levels (nonsurvivor group).</td>
</tr>
<tr>
<td style="text-align: left;">
  <code>mean.g1</code> </td>
<td style="text-align: left;"> mean CK level (nonsurvivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>sd.g1</code> </td>
<td style="text-align: left;"> standard deviation of the CK levels (nonsurvivor group).</td>
</tr>
<tr>
<td style="text-align: left;">
  <code>n.g2</code> </td>
<td style="text-align: left;"> number of subjects (survivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>q1.g2</code> </td>
<td style="text-align: left;"> first quartile of the CK levels (survivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>med.g2</code> </td>
<td style="text-align: left;"> median CK level (survivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>q3.g2</code> </td>
<td style="text-align: left;"> third quartile of the CK levels (survivor group).</td>
</tr>
<tr>
<td style="text-align: left;">
  <code>mean.g2</code> </td>
<td style="text-align: left;"> mean CK level (survivor group). </td>
</tr>
<tr>
<td style="text-align: left;">
  <code>sd.g2</code> </td>
<td style="text-align: left;"> standard deviation of the CK levels (survivor group).</td>
</tr>
</table>
<h3>References</h3>

<p>Katzenschlager S., Zimmer A.J., Gottschalk C., Grafeneder J., Seitel A., Maier-Hein L., Benedetti A., Larmann J., Weigand M.A., McGrath S., and Denkinger C.M. (2021). Can we predict the severe course of COVID-19 - A systematic review and meta-analysis of indicators of clinical outcome? <em>PLOS One</em>, <strong>16</strong>, e0255154.
</p>
<p>Qi X., Liu Y., Wang J., Fallowfield J.A., Wang J., Li X., Shi J., Pan H., Zou S., Zhang H., and others. (2021). Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: A multicentre cohort study, <em>Gut</em>, <strong>70</strong>, 433â€“436.
</p>


</div>